These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 7710667

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Neuromelanin of the human substantia nigra: an update.
    Zucca FA, Basso E, Cupaioli FA, Ferrari E, Sulzer D, Casella L, Zecca L.
    Neurotox Res; 2014 Jan; 25(1):13-23. PubMed ID: 24155156
    [Abstract] [Full Text] [Related]

  • 25. In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson's disease.
    Gonzalez-Sepulveda M, Compte J, Cuadros T, Nicolau A, Guillard-Sirieix C, Peñuelas N, Lorente-Picon M, Parent A, Romero-Giménez J, Cladera-Sastre JM, Laguna A, Vila M.
    Brain; 2023 Mar 01; 146(3):1040-1052. PubMed ID: 36717986
    [Abstract] [Full Text] [Related]

  • 26. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?
    Youdim MB, Ben-Shachar D, Riederer P.
    Acta Neurol Scand Suppl; 1989 Mar 01; 126():47-54. PubMed ID: 2618593
    [Abstract] [Full Text] [Related]

  • 27. Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease.
    Gerlach M, Double KL, Ben-Shachar D, Zecca L, Youdim MB, Riederer P.
    Neurotox Res; 2003 Mar 01; 5(1-2):35-44. PubMed ID: 12832223
    [Abstract] [Full Text] [Related]

  • 28. Influence of neuromelanin on oxidative pathways within the human substantia nigra.
    Double KL, Ben-Shachar D, Youdim MB, Zecca L, Riederer P, Gerlach M.
    Neurotoxicol Teratol; 2002 Mar 01; 24(5):621-8. PubMed ID: 12200193
    [Abstract] [Full Text] [Related]

  • 29. Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease.
    Krainc T, Monje MHG, Kinsinger M, Bustos BI, Lubbe SJ.
    Mov Disord; 2023 Feb 01; 38(2):185-195. PubMed ID: 36350228
    [Abstract] [Full Text] [Related]

  • 30. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
    Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y.
    J Neurochem; 1991 Feb 01; 56(2):446-51. PubMed ID: 1988548
    [Abstract] [Full Text] [Related]

  • 31. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
    Hirsch E, Graybiel AM, Agid YA.
    Nature; 1988 Jul 28; 334(6180):345-8. PubMed ID: 2899295
    [Abstract] [Full Text] [Related]

  • 32. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.
    Good PF, Olanow CW, Perl DP.
    Brain Res; 1992 Oct 16; 593(2):343-6. PubMed ID: 1450944
    [Abstract] [Full Text] [Related]

  • 33. Possible role of neuromelanin in the pathogenesis of Parkinson's disease.
    Mann DM, Yates PO.
    Mech Ageing Dev; 1983 Feb 16; 21(2):193-203. PubMed ID: 6865505
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Melanin and Neuromelanin Fluorescence Studies Focusing on Parkinson's Disease and Its Inherent Risk for Melanoma.
    Leupold D, Szyc L, Stankovic G, Strobel S, Völker HU, Fleck U, Müller T, Scholz M, Riederer P, Monoranu CM.
    Cells; 2019 Jun 15; 8(6):. PubMed ID: 31208049
    [Abstract] [Full Text] [Related]

  • 36. Does oxidative stress participate in nerve cell death in Parkinson's disease?
    Hirsch EC.
    Eur Neurol; 1993 Jun 15; 33 Suppl 1():52-9. PubMed ID: 8375433
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Current views on the mechanisms of dopaminergic neuron death of the nigrostriatal system in Parkinson's disease].
    Bertrand E, Lechowicz W, Szpak GM, Dymecki J.
    Neurol Neurochir Pol; 1997 Jun 15; 31(2):295-302. PubMed ID: 9380259
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.